v3.26.1
Condensed Statements of Cash Flows - USD ($)
 7 Months Ended 12 Months Ended
Dec. 31, 2024
Dec. 31, 2025
Archimedes Tech SPAC Partners II Co    
Cash Flows from Operating Activities:    
Net income (loss) $ (78,700) [1] $ 7,986,738
Adjustments to reconcile net income (loss) to net cash used in operating activities:    
Interest earned on cash held in Trust Account   (8,710,969)
Changes in operating assets and liabilities:    
Prepaid expenses   (111,403)
Accrued expenses 23,000 38,277
Prepaid insurance   (9,896)
Net cash used in operating activities   (739,050)
Cash Flows from Investing Activities:    
Investment of cash in Trust Account   (231,150,000)
Net cash used in investing activities   (231,150,000)
Cash Flows from Financing Activities:    
Proceeds from sale of Units, net of underwriting discounts paid   225,400,000
Proceeds from sale of Private Placement Units   8,400,000
Repayment of due to related party   (15,364)
Proceeds from promissory note - related party   40,927
Repayment of promissory note-related party   (290,000)
Payment of offering costs   (283,747)
Net cash provided by financing activities   233,251,816
Net Change in Cash   1,362,766
Cash - Beginning of period   0
Cash - End of period 0 1,362,766
Non-Cash investing and financing activities:    
Offering costs included in accrued offering costs 268,358 75,000
Offering costs paid by Sponsor in exchange for the issuance of Founder Shares 21,120 0
Offering costs paid through promissory note - related party 140,213 5,440
Deferred underwriting fee payable   8,050,000
Nonrelated Party [Member] | Archimedes Tech SPAC Partners II Co    
Adjustments to reconcile net income (loss) to net cash used in operating activities:    
General and administrative expenses paid by Sponsor in exchange for issuance of Founder Shares 3,880 0
Related Party [Member] | Archimedes Tech SPAC Partners II Co    
Adjustments to reconcile net income (loss) to net cash used in operating activities:    
General and administrative expenses paid by Sponsor in exchange for issuance of Founder Shares   16,603
General and administrative expenses paid through promissory note - related party $ 51,820 $ 51,600
[1] As of December 31, 2024, included an aggregate of up to 750,000 ordinary shares that were subject to forfeiture depending on the extent to which the underwriters’ over-allotment option was exercised (see Note 5). On February 12, 2025, the Company consummated its Initial Public Offering and sold 23,000,000 Units, including 3,000,000 Units sold pursuant to the full exercise of the underwriters’ option to purchase additional units to cover the over-allotment; as a result, the 750,000 ordinary shares were no longer subject to forfeiture.